BIT 6.67% 3.2¢ biotron limited

Ann: Letter to Shareholders, page-331

  1. 8,059 Posts.
    lightbulb Created with Sketch. 1085
    It was updated in the Presentation to Shareholders on the 24th October 2023

    "Headline results for all three trials expected late 2023"

    • "These studies are key to positioning of BIT225 for partnering"
    Last edited by $$$$$$$$: 15/11/23
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.